explore -WSS

explore

author：entertainment 2025-09-01 05:58:06 - browse：56

Diversity in clinical trials concept — Adobe

The persistent lack of diversity among participants in clinical trials is a critical issue that is harming both populations that have long been left out of pivotal medical studies and the entire biomedical research enterprise, according to the authors of a report released Tuesday by the National Academies of Sciences, Engineering and Medicine.

Describing the need to move away from trials that focus largely on white men as “urgent,” the report’s authors called for a paradigm shift that gives less power to institutions that fund and conduct clinical research and more to communities under study. The sternly worded report said funding to include and recruit more diverse participants should be a priority that is enforced and said such investments could eventually lead to massive cost savings as the nation’s health disparities are reduced.

“An equitable clinical research enterprise would include trials and studies that match the demographics of the disease burden under study,” the report said. “However, we remain far from achieving this goal.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Even great ERs can’t make up for American health disparities

WSS

Time to name cancers by genetics, not organ of origin, expert says

Study finds new variant for Parkinson’s in African populations

Neuroscience startup Neumora files for IPO

What we need to know about Arena Bioworks

Feds fine Medicare Advantage plans for overcharging members

SAMSHA loosens regulations on methadone treatment centers

focus

explore

knowledge

Medical leaders decry Supreme Court decision on affirmative action

2024 GOP presidential candidates spar over abortion in debate

Supreme Court strikes down use of affirmative action

FDA panel gives mixed vote on blood pressure devices

Wildfire smoke exposes gaps in outdoor worker protections

Medicare drug price negotiation’s day in court

DIEP, the 'gold standard' of breast reconstruction, is under threat

ARCH Venture Partners is raising $3 billion for a life sciences fund

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare explains how it will choose drugs for negotiation

leisure time

Cognito secures funding to test medical device for Alzheimer's

How Long Island became the ‘eugenics capital of the world’

Australia’s approach to dialysis celebrates life

Drug firms test therapies to halt Alzheimer’s before symptoms arise

Novo Nordisk to expand supply of Wegovy for U.S. patients

What we need to know about Arena Bioworks

Wikipedia

explore

knowledge

focus